Safety and preliminary efficacy of deep transcranial magnetic stimulation in MS-related fatigue
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To conduct a randomized, sham-controlled phase I/IIa study to evaluate the safety and preliminary efficacy of deep brain H-coil repetitive transcranial magnetic stimulation (rTMS) over the prefrontal cortex (PFC) and the primary motor cortex (MC) in patients with MS with fatigue or depression (NCT01106365). METHODS: Thirty-three patients with MS were recruited to undergo 18 consecutive rTMS sessions over 6 weeks, followed by follow-up (FU) assessments over 6 weeks. Patients were randomized to receive high-frequency stimulation of the left PFC, MC, or sham stimulation. Primary end point was the safety of stimulation. Preliminary efficacy was assessed based on changes in Fatigue Severity Scale (FSS) and Beck Depression Inventory scores. Randomization allowed only analysis of preliminary efficacy for fatigue. RESULTS: No serious adverse events were observed. Five patients terminated participation during treatment due to mild side effects. Treatment resulted in a significant median FSS decrease of 1.0 point (95%CI [0.45,1.65]), which was sustained during FU. CONCLUSIONS: H-coil rTMS is safe and well tolerated in patients with MS. The observed sustained reduction in fatigue after subthreshold MC stimulation warrants further investigation. CLINICALTRIALSGOV IDENTIFIER: NCT01106365. CLASSIFICATION OF EVIDENCE: This study provides Class III evidence that rTMS of the prefrontal or primary MC is not associated with serious adverse effects, although this study is underpowered to state this with any precision.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
Polman, C. H., Reingold, S. C., Edan, G., Filippi, M., Hartung, H., Kappos, L., Lublin, F. D., Metz, L. M., McFarland, H. F., O'Connor, P. W., et al. (2005) · Annals of Neurology · doi:10.1002/ana.20703 · Cited by 5,017
Rossini, P. M., Barker, A. T., Berardelli, A., Caramia, M. D., Caruso, G., Cracco, R. Q., Dimitrijević, M. R., Hallett, M., Katayama, Y., Lücking, C. H., et al. (1994) · Electroencephalography and Clinical Neurophysiology · doi:10.1016/0013-4694(94)90029-9 · Cited by 3,030
Fatigue in multiple sclerosis and its relationship to depression and neurologic disability
Bakshi, R., Shaikh, Z. A., Miletich, R. S., Czarnecki, D., Dmochowski, J., Henschel, K., Janardhan, V, Dubey, N., & Kinkel, P. R. (2000) · Multiple Sclerosis Journal · doi:10.1177/135245850000600308 · Cited by 480 · cited 1×
“PFC and MC stimulation directly targets circuits for which alterations in fatigue were reported, and PFC stimulation is supported by the high overlap between fatigue and depressive symptoms.(19) MC stimulation, on the other hand, may also lead to an additional improvement of fatigue via reduction of spasticity.”
BackgroundLevkovitz, Y., Isserles, M., Padberg, F., Lisanby, S. H., Bystritsky, A., Xia, G., Tendler, A., Daskalakis, Z. J., Winston, J. L., Dannon, P., et al. (2015) · World Psychiatry · doi:10.1002/wps.20199 · Cited by 442 · cited 3×
“As these regions are within the reach of the H-coil, it is conceivable that deep TMS may at least in part and temporarily normalize the impaired functional connectivity and thus improve fatigue—similar to mechanisms thought to be involved in the reduction of depressive symptoms in MDD following rTMS.(18) Although we f…”
BackgroundMethodResultInfluentialSelf-citationBersani, F. S., Minichino, A., Enticott, P. G., Mazzarini, L., Khan, N., Antonacci, G., Raccah, R. N., Salviati, M., Delle Chiaie, R., Bersani, G., et al. (2013) · European Psychiatry · doi:10.1016/j.eurpsy.2012.02.006 · Cited by 169 · cited 1×
“28 Fifteen percent of patients discontinued before completion of the study, with the majority (3 of 5 patients) reporting scalp discomfort and head-ache as reasons.”
Background
Cited by
Lefaucheur, J.-P., Aleman, A., Baeken, C., Benninger, D. H., Brunelin, J., Di Lazzaro, V., Filipović, S. R., Grefkes, C., Hasan, A., Hummel, F. C., et al. (2020) · Clinical Neurophysiology · doi:10.1016/j.clinph.2019.11.002 · Cited by 2,382
“Finally, one study (Gaede et al., 2017) assessed the efficacy of a non-focal HF-rTMS of the left prefrontal cortex (PFC) using an H6coil (1800 pulses/session delivered at 18 Hz and 120% of RMT) in 19 MS patients (9 real, 10 sham), while a third group of 9 MS patients received a non-focal…”
Rossi, S., Antal, A., Bestmann, S., Bikson, M., Brewer, C., Brockmöller, J., Carpenter, L. L., Cincotta, M., Chen, R., Daskalakis, J. D., et al. (2021) · Clinical Neurophysiology · doi:10.1016/j.clinph.2020.10.003 · Cited by 1,573
“Although the absolute risk of seizure remains low (Gaede et al., 2018; Jorge et al., 2004; Tarapore et al., 2016), there are cases in which TMS delivered close to brain lesions has induced seizure (Cogné et al.”
Self-citationFilippi, M., Bar-Or, A., Piehl, F., Preziosa, P., Solari, A., Vukusic, S., & Rocca, M. A. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0041-4 · Cited by 1,562
Snow, N. J., Wadden, K. P., Chaves, A. R., & Ploughman, M. (2019) · Neural Plasticity · doi:10.1155/2019/6430596 · Cited by 56
Nguyen, P. T., Makowiecki, K., Lewis, T. S., Fortune, A. J., Clutterbuck, M., Reale, L. A., Taylor, B. V., Rodger, J., Cullen, C. L., & Young, K. M. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05391-0 · Cited by 21
“However, these clinical studies did not explore the impact of rTMS on remyelination.”
Background
Metadata
- Authors
- Gaede, G., Tiede, M., Lorenz, I., Brandt, A. U., Pfueller, C., Dörr, J., Bellmann-Strobl, J., Piper, S. K., Roth, Y., Zangen, A., Schippling, S., & Paul, F.
- Venue
- Neurology Neuroimmunology & Neuroinflammation
- Published
- 2018-01
- Volume
- 5
- Issue
- 1
- Pages
- e423-e423
- ISSN
- 2332-7812 (ISSN-L)
- OpenAlex
- W2773660084
- Cited by
- 75
- References
- 5
- FWCI
- 3.80
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Safety and preliminary efficacy of deep transcranial magnetic stimulation in MS-related fatigue. https://app.cochat.ai/papers/10.1212/nxi.0000000000000423
- The paper
- Gaede, G., Tiede, M., Lorenz, I., Brandt, A. U., Pfueller, C., Dörr, J., Bellmann-Strobl, J., Piper, S. K., Roth, Y., Zangen, A., Schippling, S., & Paul, F. (2018). Safety and preliminary efficacy of deep transcranial magnetic stimulation in MS-related fatigue. Neurology Neuroimmunology & Neuroinflammation. https://doi.org/10.1212/nxi.0000000000000423
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.